Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PIG-A mutations in normal hematopoiesis.

Rong Hu1, Galina L Mukhina, Steven Piantadosi

  • 1Johns Hopkins University, School of Medicine, Division of Hematology, Baltimore, MD 21205, USA.

Blood
|February 3, 2005
PubMed
Summary

Spontaneous phosphatidylinositol glycan-class A (PIG-A) mutations occur in differentiated progenitors, not hematopoietic stem cells (HSCs), in healthy individuals. These mutations are polyclonal, unlike the clonal PIG-A mutations found in paroxysmal nocturnal hemoglobinuria (PNH).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study.

Haematologica·2026
Same author

PT/Cy-based alloBMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemia.

Blood advances·2026
Same author

Correction: PIGN spatiotemporally regulates the spindle assembly checkpoint proteins in leukemia transformation and progression.

Scientific reports·2026
Same author

Noninvasive Monitoring of Complement Using the Bioluminescent Modified Ham Assay in the Second Porcine-to-Human Live Heart Transplant.

Xenotransplantation·2026
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

Blood advances·2026
Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Paroxysmal nocturnal hemoglobinuria (PNH) arises from phosphatidylinositol glycan-class A (PIG-A) mutations in hematopoietic stem cells (HSCs).
  • PIG-A mutations are frequently detected in granulocytes of healthy individuals, hinting at their potential role in PNH pathogenesis.
  • The relevance of these spontaneous mutations in healthy individuals to PNH remains uncertain.

Purpose of the Study:

  • To investigate the clonality and origin of PIG-A mutations in hematopoietic progenitors from PNH patients and healthy controls.
  • To determine if PIG-A mutations in healthy individuals arise from HSCs or more differentiated progenitors.

Main Methods:

  • Isolation of CD34+ progenitors from 4 PNH patients and 27 healthy donors.

Related Experiment Videos

  • Assay for aerolysin-resistant colony-forming cells (CFCs) to quantify PIG-A mutant progenitors.
  • DNA sequencing of the PIG-A gene in individual aerolysin-resistant CFCs to assess clonality.

    • Main Results:

    • Aerolysin-resistant CFCs from PNH patients showed clonal PIG-A mutations.
    • In contrast, PIG-A mutations in CFCs from healthy controls were polyclonal.
    • These polyclonal mutations in controls did not involve T cells and appeared to originate in differentiated progenitors, not HSCs.

    Conclusions:

    • PIG-A mutations are common in normal hematopoiesis but occur in differentiated progenitors, not HSCs.
    • The polyclonal nature of these mutations in healthy individuals distinguishes them from the clonal mutations seen in PNH.
    • This suggests a different mechanism or significance for spontaneous PIG-A mutations in healthy individuals compared to PNH.